Table 3.
dose (mg/kg) | days Rx | % survival + comments |
---|---|---|
300 | 3 | 1/5 lethality after 3 days of dosing, 1/5 additional lethality after 3 days of dosing |
100 | 3 | transient lethargy after dosing |
30 | 3 | no adverse effects |
dose (mg/kg) | days Rx | % survival + comments |
---|---|---|
300 | 3 | 1/5 lethality after 3 days of dosing, 1/5 additional lethality after 3 days of dosing |
100 | 3 | transient lethargy after dosing |
30 | 3 | no adverse effects |